- CLARIOstar® with ACU provides a system where real-time measurements can be performed in a controlled environment
- The multiplexed RealTime-GloTM Annexin V Apoptosis and Necrosis Assay reagent detects phosphatidylserine exposure events associated with apoptosis while also reporting loss of membrane integrity resulting from necrosis
Table of contents
Cell death is important for multicellular homeostasis but it also has an unfortunate role in human diseases. Discovery of targeted cytotoxic and cytoprotective agents is vital for treating cancer or neurodegeneration. In order characterize the dysregulation in a disease model, and responses to experimental stimuli, it is important to define the mechanism of cell death and response kinetics. Traditional experimental approaches are often time consuming, labor intensive, costly and inadequate.
Here we describe Promega’s new RealTime-Glo™ Annexin V Apoptosis and Necrosis Assay that provides the simplicity of an add-mix-measure assay, in a live-cell, real-time format. While the CLARIOstar with atmospheric control unit (ACU) provides the sensitive detection of duplexed luminescent and fluorescent signals it maintains appropriate [O2] and [CO2] environment for your cells. This combination allows walking away once the test is set up and ensures that you will not miss important cellular responses regardless of when changes happen.
Although cell death is an important, normal consequence of multicellular homeostasis it also has an unfortunate role in many human diseases. Discovery of targeted cytotoxic and cytoprotective agents may therefore have important implications in treating cancer, neurodegeneration and a litany of other diseases. In order to fully appreciate the dysregulation in a disease model, and responses to experimental stimuli, it is important establish the mechanism of action of cell death and deﬁne response kinetics. Traditional experimental approaches for addressing mode of cell death are often time consuming, labor intensive, costly and inadequate.
Here we describe the monitoring of apoptosis and necrosis in real time. Promega’s new RealTime-GloTM Annexin V Apoptosis and Necrosis Assay provides the simplicity of an add-mix-measure assay, in a live-cell, real-time format. While the CLARIOstar with atmospheric control unit (ACU) provides the sensitive detection of duplexed luminescent and ﬂuorescent signals, all while maintaining the appropriate [O2] and [CO2] environment for your cells. This combination will allow you to walk away once the test is set up and ensures that you will not miss important cellular responses regardless of when changes happen.
Translocation of phosphatidylserine (PS) from the inner to outer membrane leaﬂet is considered a hallmark of healthy cells transitioning to apoptosis1. Multiple assays take advantage of Annexin V binding to PS to identify cells beginning apoptosis.
The RealTime-Glo™ Annexin V Apoptosis and Necrosis assay utilizes annexin-fusion proteins that contain binary subunits of a luminescent enzyme2 (NanoBiT™) which are drawn into complementing proximity only due to their afﬁnity for PS. In the presence of a time-released substrate, the complemented enzymes report real-time PS exposure. The Necrosis Detection Reagent reports changes in membrane integrity as a result of necrosis. Together, these real-time measures establish the mechanism of action (apoptosis, primary necrosis, or alternative programs) for cell death.
Materials & Methods
- RealTime-GloTM Annexin V Apoptosis and Necrosis Assay (Promega, Cat #JA1011)
- CLARIOstar® with ACU (BMG LABTECH)
- White, clear or opaque bottom, 96-well plates (Costar)
- K562 cells from ATCC®
- Negatively-selected Natural killer (NK) cells from Lonza
- Other reagents from commercially available sources
The RealTime-Glo™ Annexin V Apoptosis and Necrosis Assay reagent was prepared as indicated in the technical manual and added at the time of dosing or treatment.
For the dose response experiments, an 8 point dilution series of bortezomib with a maximum concentration of 10 μM was applied to K562 cells pre-seeded at 10,000 cells per well. A vehicle treatment and cell-free blank were also included.
For NK cell experiments, NK cells were stimulated with IL-15 then added to K562 cells in the indicated ratios. NK or K562 cells alone served as exposure controls. Measurement and incubation were accomplished with the CLARIOstar microplate reader using a script and the following settings.
|RealTime-Glo™ Annexin V Apoptosis detection|
|Optic settings||Luminescence, bottom optic|
|General settings||Measurement interval time||1.0 s|
|Optic settings||Fluorescence intensity, top optic|
|Filters||Excitation 482-16 |
|Gain||Adjusted prior to run|
|General settings||Settling time||0.2 s|
|No. of flashes||40|
|Kinetics and atmospheric control|
|Kinetic settings||Number of cycles and cycle times are indicated individually for each experiment|
|ACU||5 % CO2 and monitoring of oxygen|
Results & Discussion
The CLARIOstar with ACU enabled the real-time du-plexed detection of a luminescent and ﬂuorescent signal every hour throughout the 48 hour exposure to bortezomib (49 cycles). In ﬁgure 2 the PS-exposure response (luminescence) precedes the necrotic response (ﬂuorescence) indicating the expected apoptotic mechanism for this therapeutic proteasome inhibitor.
Figure 3 illustrates time-dependent dose response curves that can be generated from a single experiment. The results reinforce the relationship between dose and time with respect to response magnitude. Similar results were generated to examine the change in membrane integrity as a result of the secondary ne-crotic response (data not shown).
The ﬁnal example explored the innate ability of stimulated natural killer (NK) cells to target, engage and induce apoptosis in a K562 cancer cell population. Speciﬁcally, kinetic readings of the admixed cells were taken every 5 minutes over a two hour time course (25 cycles). The data indicated that PS-exposure and cell death proceeded in a NK cell number dependent manner with a maximal response to a high ratio of NK cells obtained at 2 hours (data not shown).
Figure 4 displays the correlation between increasing the ratio of NK cells to target cells and an increase in luminescent signal indicative of apoptosis.
The results show a combination of a novel assay methodology and instrumentation that allows the user to truly walk away and return to outstanding results. The real-time nature of the results allows you to capture information that would require extensive effort to be achieved using previous apoptosis assay techniques.
1. S.J. Martin et al. (1995) J. Exp. Med. 182, 1545-1556.
2. A. S. Dixon et al. (2016) ACS Chem. Biol. 11, 400-408.